Procalcitonin as an early predictor of contrast-induced acute kidney injury in patients with acute coronary syndromes who underwent percutaneous coronary intervention

Angiology

Volumn 66, Issue 10, 2015, Pages 957-963

  Kurtul, Alparslan ^a   Murat, Sani Namik ^a   Yarlioglues, Mikail ^a   Duran, Mustafa ^a   Ocek, Adil Hakan ^a   Celik, Ibrahim Etem ^a   Kilic, Alparslan ^a   Koseoglu, Cemal ^a   Oksuz, Fatih ^a   Baris, Veysel Ozgur ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

acute coronary syndrome; contrast induced acute kidney injury; percutaneous coronary intervention; procalcitonin

Indexed keywords

CREATINE KINASE; CREATININE; HEMOGLOBIN; PROCALCITONIN; AUTACOID; BIOLOGICAL MARKER; CALCITONIN; CONTRAST MEDIUM; PROTEIN PRECURSOR;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CONTRAST INDUCED ACUTE KIDNEY INJURY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; RISK FACTOR; SYNTAX SCORE; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ANGIOCARDIOGRAPHY; BLOOD; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; COMPLICATION; EARLY DIAGNOSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE; RADIOGRAPHY; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UPREGULATION; VERY ELDERLY;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; BIOMARKERS; CALCITONIN; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; EARLY DIAGNOSIS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84943554012     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319715572218     Document Type: Article

References (43)

1. McCullough PA,. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008; 51 (15): 1419-1428.
2. Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003; 108 (22): 2769-2775.
3. Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004; 44 (9): 1780-1785.
4. Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Wiviott SD,. Short term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry. Circulation. 2012; 125 (3): 497-504.
5. McCullough PA, Stacul F, Becker CR, et al. CIN Consensus Working Panel. Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary. Rev Cardiovasc Med. 2006; 7 (4): 177-197.
6. Senoo T, Motohiro M, Kamihata H, et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2010; 105 (5): 624-628.
7. Tepel M, Aspelin P, Lameire N,. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation. 2006; 113 (14): 1799-1806.
8. Murat SN, Kurtul A, Yarlioglues M,. Impact of serum albumin levels on contrast-induced acute kidney injury in patients with acute coronary syndromes treated with percutaneous coronary intervention. Angiology. 2014. doi: 10.1177/0003319714551979.
9. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105 (19): 2259-2264.
10. Lemay S, Rabb H, Postler G, Singh AK,. Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation. 2000; 69 (5): 959-963.
11. Ramesh G, Reeves WB,. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest. 2002; 110 (6): 835-842.
12. Chang CF, Lu TM, Yang WC, Lin SJ, Lin CC, Chung MY,. Gene polymorphisms of interleukin-10 and tumor necrosis factor-α are associated with contrast-induced nephropathy. Am J Nephrol. 2013; 37 (2): 110-117.
13. Okusa MD,. The inflammatory cascade in acute ischemic renal failure. Nephron. 2002; 90 (2): 133-138.
14. Meisner M,. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta. 2002; 323 (1-2): 17-29.
15. Müller B, White JC, Nylén ES, Snider RH, Becker KL, Habener JF,. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001; 86 (1): 396-404.
16. Kafkas N, Venetsanou K, Patsilinakos S, et al. Procalcitonin in acute myocardial infarction. Acute Card Care. 2008; 10 (1): 30-36.
17. Buratti T, Ricevuti G, Pechlaner C, et al. Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation. 2001; 25 (2): 97-100.
18. Remskar M, Horvat M, Hojker S, Noc M,. Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr. 2002; 114 (5-6): 205-210.
19. Ataoʇlu HE, Yilmaz F, Uzunhasan I, et al. Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome. J Int Med Res. 2010; 38 (1): 52-61.
20. Kelly D, Khan SQ, Dhillon O, Quinn P, Struck J, Squire IB, et al. Procalcitonin as a prognostic marker in patients with acute myocardial infarction. Biomarkers. 2010; 15 (4): 325-331.
21. Sentürk T, Cordan J, Baran I, et al. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol. 2007; 62 (2): 135-141.
22. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44 (7): 1393-1399.
23. Levey AS, Coresh J, Greene T, et al. Chronic kidney disease epidemiology collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145 (4): 247-254.
24. Lang RM, Bierig M, Devereux RB, et al. Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18 (12): 1440-1463.
25. Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP,. Contrast-Induced Nephropathy: An "All or None" Phenomenon? Angiology. 2014. doi: 10.1177/0003319714550309.
26. Goldenberg I, Matetzky S,. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005; 172 (11): 1461-1471.
27. Heyman SN, Rosen S, Khamaisi M, Idee JM, Rosenberger C,. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol. 2010; 45. 188-195.
28. Tumlin J, Stacul F, Adam A, et al. Consensus Working Panel. Pathophysiology of contrast-induced nephropathy. Am J Cardiol. 2006; 98 (6A): 14K-20K.
29. Günebakmaz O, Duran M, Karakaya E, et al. Increased serum asymmetric dimethylarginine level is an independent predictor of contrast-induced nephropathy. Turk Kardiyol Dern Ars. 2013; 41 (7): 581-588.
30. Fiorina P, Ansari MJ, Jurewicz M, et al. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol. 2006; 17 (3): 716-723.
31. Kielar ML, John R, Bennett M, et al. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol. 2005; 16 (11): 3315-3325.
32. Patti G, Ricottini E, Nusca A, et al. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty - contrast-induced nephropathy] trial. Am J Cardiol. 2011; 108 (1): 1-7.
33. Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F,. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome). J Am Coll Cardiol. 2014; 63 (1): 71-79.
34. Gao F, Zhou YJ, Zhu X, Wang ZJ, Yang SW, Shen H,. C-reactive protein and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Am J Nephrol. 2011; 34 (3): 203-210.
35. Liu Y, Tan N, Zhou YL, et al. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention. J Nephrol. 2012; 25 (3): 332-340.
36. Altunhan H, Annagür A, Örs R, Mehmetoʇlu I,. Procalcitonin measurement at 24 hours of age may be helpful in the prompt diagnosis of early-onset neonatal sepsis. Int J Infect Dis. 2011; 15 (12): e854-e858.
37. Sinning CR, Sinning JM, Schulz A, et al. AtheroGene Study Investigators. Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease. Circ J. 2011; 75 (5): 1184-1191.
38. Massaro KS, Costa SF, Leone C, Chamone DA,. Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis. 2007; 7: 137.
39. Meisner M, Adina H, Schmidt J,. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care. 2006; 10 (1): R1.
40. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Müller B,. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med. 2004; 32 (8): 1715-1721.
41. Heyman SN, Rosen S, Rosenberger C,. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol. 2008; 3 (1): 288-296.
42. Raddant AC, Russo AF,. Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia. Headache. 2014; 54 (3): 472-484.
43. Haller C, Hizoh I,. The cytotoxicity of iodinated radiocontrast agents on Renal cells in vitro. Invest Radiol. 2004; 39 (3): 149-154.